FACT SHEET

SANOFI PASTEUR’S TORONTO SITE, CANADA PUTTING ONTARIO AT THE HEART OF GLOBAL VACCINE INNOVATION

SANOFI PASTEUR IN BRIEF • Sanofi Pasteur, the vaccines division of Sanofi, is a global company that provides more than one billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. • Sanofi Pasteur’s global head office is located in Lyon, France. • Sanofi Pasteur’s Canadian Headquarters is located at: 1755 Steeles Avenue West, Toronto, Ontario

A CENTURY OF INNOVATION • Founded in 1914, Sanofi Pasteur Canada is among the country’s largest vaccine companies, with a proud legacy of innovations in public health. • We research, develop, manufacture and distribute life-saving vaccines for the Canadian, U.S. and international markets.

PROVIDING VACCINES TO MEET GLOBAL PUBLIC HEALTH NEEDS • Our Toronto site manufactures nine products to help protect people against infectious diseases such as pertussis, diphtheria and tetanus. These products include: ® ® ® ® ® ® o Pentacel , Pediacel , Adacel , Adacel -Polio, Quadracel , Daptacel , Td Adsorbed, Td Polio Adsorbed, and Tubersol® • At the site we produce the five-component-pertussis (5cP) antigen, which helps to protect children and adults against whooping cough. • The site is home to our North American “Centre of Excellence” for bioprocess and analytical R&D – a $100 million R&D facility opened in 2011, putting Ontario at the heart of global vaccine innovation.

A HISTORIC CAMPUS • Sanofi Pasteur Canada was founded in 1914 as the “Antitoxin Laboratory” within the University of Toronto and expanded facilities opened on a sprawling North Toronto farm property in 1917. • Throughout a number of mergers, acquisitions and name changes, we have partnered with public health authorities, governments, and academia. • Significant public health contributions include the pioneering development of antitoxins, insulin, heparin, polio vaccines, combination vaccines, and more. • Today, the site’s 54 acres serves as office space, R&D labs, vaccine-manufacturing facilities and heritage sites, and is home to over 1,400 employees in Industrial operations, R&D, Commercial operations, and various support functions.

1/1